Health
Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination – News-Medical.Net
New research from a team of scientists in Australia finds that the second ‘booster’ dose of the Pfizer-BioNTech vaccine did not increase vaccine efficacy against…
New research from a team of scientists in Australia suggests that the second ‘booster’ dose of the Pfizer-BioNTech vaccine may not increase vaccine efficacy against severe acute respiratory syndrome (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19).
The results suggest one dose of the vaccine could be sufficient in providing a robust immune response 11 days after inoculation.
The findings could help shape policy as vaccine rollout has been slow in countries such as the United…
-
Noosa News17 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General21 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News18 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
General14 hours agoQantas ‘contacted by potential cybercriminal’ after attack on data of up to 6 million customers